Document is current
Any future updates will be listed below
-
Authors
Ding, Lina
Su, Ying
Fassl, Anne
Hinohara, Kunihiko
Qiu, Xintao
Harper, Nicholas W.
Huh, Sung Jin
Bloushtain-Qimron, Noga
Jovanović, Bojana
Ekram, Muhammad
Zi, Xiaoyuan https://orcid.org/0000-0002-2374-9001
Hines, William C.
Alečković, Maša https://orcid.org/0000-0001-5653-8502
Gil del Alcazar, Carlos
Caulfield, Ryan J.
Bonal, Dennis M. https://orcid.org/0000-0002-7805-1209
Nguyen, Quang-De
Merino, Vanessa F.
Choudhury, Sibgat
Ethington, Gabrielle
Panos, Laura
Grant, Michael
Herlihy, William
Au, Alfred
Rosson, Gedge D.
Argani, Pedram
Richardson, Andrea L.
Dillon, Deborah
Allred, D. Craig
Babski, Kirsten
Kim, Elizabeth Min Hui
McDonnell, Charles H. III
Wagner, Jon
Rowberry, Ron
Bobolis, Kristie
Kleer, Celina G.
Hwang, E. Shelley
Blum, Joanne L.
Cristea, Simona
Sicinski, Piotr https://orcid.org/0000-0002-8859-5234
Fan, Rong https://orcid.org/0000-0001-7805-8059
Long, Henry W. https://orcid.org/0000-0001-6849-6629
Sukumar, Saraswati
Park, So Yeon
Garber, Judy E.
Bissell, Mina https://orcid.org/0000-0001-5841-4423
Yao, Jun
Polyak, Kornelia https://orcid.org/0000-0002-5964-0382
-
Funding
Funding for this research was provided by:
Susan G. Komen
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA202634, CA080111, CA143233, CA080111, R35CA197623, CA202634)
- License Information
-
More Information
Article History
Received: 7 July 2018
Accepted: 21 August 2019
First Online: 13 September 2019
Competing interests
: K.P. currently serves on the Scientific Advisory Board of Mitra Biotech and Acrivon Therapeutics and used to be a consultant to Novartis. D.D. is a consultant for Novartis and serves on the Academic Advisory Board of Oncology Analytics, Inc. J.L.B. is a consultant for Pfizer, Medivation, and Amgen. P.S. has been a consultant to Novartis, Genovis, Guidepoint, The Planning Shop, ORIC Pharmaceuticals, and Exo Therapeutics; P.S. also receives research funding from Novartis. R.F. served on the Scientific Advisory Boards of IsoPlexis, BioTechne, and Singleron Biotechnologies. L.P. is a current employee of Ambry Genetics. Y.S. is a current employee of Deciphera Pharmaceuticals; S.J.H. is a current employee of ImmunoGen, Inc.; M.E. is a current employee of WuXi NextCODE; S.C. is a current employee of Metamark Genetics Inc. The remaining authors declare no competing interests.
